Alzamend Neuro Inc’s filing revealed that its 10% Owner Hyperscale Data, Inc. acquired Company’s shares for reported $0.28 million on May 12 ’25. In the deal valued at $0.54 per share,516,090 shares were bought.
Then, Horne William B. bought 3,334 shares, generating $3,285 in total proceeds. Upon buying the shares at $0.99, the Director now owns 30,000 shares.
Before that, AULT MILTON C III bought 2,905 shares. Alzamend Neuro Inc shares valued at $2,969 were divested by the Director at a price of $1.02 per share. As a result of the transaction, AULT MILTON C III now holds 85,273 shares, worth roughly $0.36 million.
Ascendiant Capital Markets initiated its Alzamend Neuro Inc [ALZN] rating to a Buy in a research note published on October 01, 2021; the price target was $8.
Price Performance Review of ALZN
On Tuesday, Alzamend Neuro Inc [NASDAQ:ALZN] saw its stock fall -18.83% to $4.18. Over the last five days, the stock has lost -26.92%. Alzamend Neuro Inc shares have fallen nearly -59.96% since the year began. Nevertheless, the stocks have fallen -92.13% over the past one year. While a 52-week high of $135.54 was reached on 01/07/25, a 52-week low of $4.59 was recorded on 05/13/25. SMA at 50 days reached $7.08, while 200 days put it at $12.99.
Levels Of Support And Resistance For ALZN Stock
The 24-hour chart illustrates a support level at 3.37, which if violated will result in even more drops to 2.56. On the upside, there is a resistance level at 5.55. A further resistance level may holdings at 6.93. The Relative Strength Index (RSI) on the 14-day chart is 29.46, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.49%. Stochastics %K at 36.57% indicates the stock is a holding.
